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This paper provides an overview of the relationship between tobacco use and early cancer mortality. It presents a retrospective examination of
trends in smoking behavior and how these trends affected the national lung cancer mortality pattern during this century. Information on smoking
prevalence is presented for black and white men and women for each 5-year birth cohort between 1885 and 1969. The author argues that the lung
cancer mortality pattern observed in the United States since 1950 is entirely compatible with changes in smoking behavior among the various birth
cohorts examined. The paper also reviews our current scientific knowledge about the etiological relationship between cigarette smoking and
site-specific cancer mortality, with particular emphasis on lung cancer. Data on other forms of tobacco use and cancer mortality risks are included as
are data on environmental tobacco smoke exposures and nonsmokers' lung cancer risk. Data are presented to demonstrate that cigarette use alone
will be responsible for nearly one-third of the U.S. cancer deaths expected in the United States in 1995, or 168,000 premature cancer deaths.
Among males, 38% of all cancer deaths are cigarette related, while among women 23% of all cancer deaths are due to cigarettes. These totals,
however, include neither the cancer deaths that could reasonably be attributed to pipe, cigar, and smokeless tobacco use among males nor the
estimated 3000 to 6000 environmental tobacco smoke-related lung cancer deaths that occur annually in nonsmokers. It is concluded that tobacco
use, particularly the practice of cigarette smoking, is the single greatest cause of excess cancer mortality in U.S. populations. - Environ Health
Perspect 103(Suppl 8):131-141 (1995)
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Introduction
This paper provides an overview, not a
detailed summary, of our current scientific
knowledge about the health effects of
tobacco use, especially the practice ofciga-
rette smoking as it relates to cancer. The
data presented are largely drawn from a
number of major reviews, including the
National Cancer Institute's (NCI) new
series of smoking and tobacco control
monographs (1-4), the annual reports of
the U.S. Surgeon General on the health
consequences of smoking (5-12), the
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periodic reports issued by the Royal
College of Physicians in Great Britain
(13-16), the World Health Organization
(WHO) (17,18), and the 1986 Report of
the International Agency for Research on
Cancer (IARC) (19).
Tobacco Use during
This Century
Despite that tobacco use has been a
significant aspect ofAmerican culture for
hundreds ofyears, the practice ofinhaling
cigarette smoke is a relatively recent phe-
nomenon and only gained widespread
acceptance during this century (20,21).
Until the introduction in the United States
of the first modern blended cigarette
(Camels) in 1913, most tobacco was con-
sumed in the form ofchewing tobacco or
smoked as cigars or in pipes (Figure 1). In
1900, for example, of the 7.5 pounds of
tobacco consumed per capita, nearly half
was consumed as chewing tobacco (3.5 lb);
just 0.16 ofa pound was consumed in the
form of machine-made, mass-produced
cigarettes (21-23). Concurrent with the
introduction of the blended cigarette, the
major cigarette manufacturers began appli-
cation ofnewly developed mass marketing
and advertising practices that substantially
increased consumer demand for these new
tobacco products. Consumption of
machine-made cigarettes increased rapidly
during and immediately after World War
I, so that by the mid-1930s more tobacco
was being consumed in cigarettes than in
all other forms oftobacco combined (23).
The practice ofcigarette smoking sub-
stantially altered the risks associated with
tobacco use compared with the use ofother
forms oftobacco, for it required the user to
inhale the smoke in order to absorb a
sufficient quantity ofnicotine. By inhaling,
the user directly exposed the lung and the
cardiovascular system to a number oftoxic
and carcinogenic agents. It would not
become scientifically known until decades
later that the smoke from a single cigarette
is composed of over 4000 different con-
stituents, including nearly 60 agents that
are known carcinogens, tumor promoters,
or tumor initiators (6,11). It was this
change in how tobacco was consumed dur-
ing the first halfofthe 20th century that is
largely responsible for the epidemic oflung
cancer and other smoking-related cancers
that occurred during the last half of the
century (21).
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Chewing increasedrapidly(7,24).
Pipe/rollyourown The pattern of initiation among white
Cigarettes women, depicted in Figure 3, is strikingly
different from that seen among their white
male counterparts, especially those born
before 1930. Among the most recent
cohorts ofwomen, initiation occurs largely
during adolescence; however, among older
cohorts (those born before 1940), initia-
tion is much slower, and among the very
oldest cohorts ofwomen, smoking initia-
tion continued well into their 30s and 40s.
There also are major differences
between men and women with respect to
their peak rate of smoking. Among the
three oldest cohorts ofwhite women (those
born before 1900), no cohort achieved a
20% lifetime smoking rate, whereas every
1900 1910 1920 1930 1940 1950 1960 1970 1980 1990 cohort of white males born between 1885
ds in per capita tobacco consumption by major product category, United States, 1890 to 1994. and 1954 experienced a 50% or higher
ed are pounds of tobacco consumed per year per adult (age 18 years and older) and represent peak rate-many achieving rates between
cessing weight. Data from Shopland (21). 60 and 80%. Only among the two most
recent birth cohorts are peak smoking rates
comparable (24).
Smoking Behavior among
Various Birth Cohorts
of Men and Women
The rapid change from other forms of
tobacco use to cigarettes did not occur uni-
formly across all major segments of the
U.S. population. Social norms at the turn
of the century limited tobacco use almost
exclusively to males, with the exception of
some limited snuff "sniffing" by women
(7,22). In fact, cigarette smoking by large
numbers of women would not become
socially acceptable until cigarette advertis-
ing began to target women in the late
1920s and early 1930s (7,24).
Differences in smoking prevalence in
women compared with men can be more
easily explained by examining changes in
smoking behavior among various birth
cohorts over time. The data that follow are
based on survey data collected by the
National Center for Health Statistics from
1965 through 1991 as analyzed by Burns
and colleagues and will be published in
more detail in an NCI smoking and
tobacco control monograph (24).
NWhite Males
Figure 2 depicts smoking prevalence by 5-
year age cohorts for white males born
between 1885 and 1969. It is evident that
the prevalence ofsmoking increases rapidly
during adolescence, and the percentage of
white males who became smokers increased
for the first several cohorts shown. The
oldest cohorts (those born before 1900),
however, have lower peak prevalence rates
compared with those ofsuccessive cohorts.
These individuals were already in early
adulthood when cigarette manufacturers
began using more sophisticated advertising
and mass marketing techniques to promote
their new machine-made cigarettes (just
before World War I) and probably were
less susceptible to such influences com-
pared with those males born after 1900,
who would have been subjected to such
advertising and promotion influences while
in their early teens (24).
White males born between 1900 and
1930 experienced similar patterns ofinitia-
tion as well as peak smoking rates. A major
characteristic of these older cohorts is the
very broad area under each cohort curve,
indicating that relatively little cessation
occurred until much later compared with
more contemporary age birth cohorts. In
contrast, these later cohorts, while experi-
encing relatively high peak rates of smok-
ing (some approaching 80%), have a much
narrower plateau, and begin to decline
almost as soon as their peak prevalence rate
is reached.
White Females
Historically, patterns ofsmoking uptake
and regular use by women have been very
different from those of men. Until the mid-
1920s when cigarette advertising began tar-
geting women, very few women smoked. As
advertising increasingly targeted women
BlackMales
Trends in smoking behavior among black
men is similar to those observed among
white men, although some differences are
worth noting. Older cohorts ofblack men
were somewhat less likely to become smok-
ers than similar cohorts ofwhite men and
their age distribution for initiation is also
somewhat older, indicating that compared
with their white male counterparts, these
cohorts have somewhat lower lifetime expo-
sures to cigarette smoke. After 1915, how-
ever, every cohort ofblack males except for
the most recent cohort (those born between
1965 and 1969) experiences a higher peak
rate than white males (Figure 4). Further-
more, this greater current smoking rate
experienced by most black male cohorts is
the result ofboth a greater peak prevalence
and a lower rate of decline in prevalence
once their peak rate is achieved. In essence,
this results in most black male cohorts hav-
ing broader plateaus than their white male
peers, indicating a longer duration of expo-
sure to cigarette smoke, which helps explain
their respective lung cancer mortality
patterns during this century (21).
BlackFemales
In contrast to males, black and white
females experience nearly identical patterns
ofsmoking uptake and cessation. With the
exception ofdifferences in the age ofinitia-
tion and lower rates ofprevalence among
the oldest cohorts of black women, the
Environmental Health Perspectives
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Figure 2. Current smoking prevalence bycalendaryearfor 5-year birth cohorts ofwhite males born between 1885 and 1969. Data from Burns et al. (24).
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Figure 3. Current smoking prevalence by calendar year for 5-year birth cohorts of white females born between 1885 and 1969. Data from Burns et al. (24).
prevalence among most cohorts of black
andwhite women is quite similar (Figure 5).
Influence ofSmoking Patterns
on Lung Cancer Mortality
As pointed out above, among the oldest
birth cohorts of males (those born before
1915), whites experienced higher peak
smoking rates and a somewhat earlier age
ofsmoking initiation than their black male
counterparts. After 1915, smoking rates
among black male birth cohorts began to
change, not only with respect to their peak
smoking behavior but also with respect to
the length oftime (duration) each ofthese
cohorts stayed at or close to their peak
before declining.
White males began to change their
behavior in the early 1950s when the first
scientific studies linking smoking and lung
cancer were published (1,21,24). Other
demographic groups were much slower to
respond to this early information and did
not begin to alter their behavior substan-
tially until the mid-to-late 1960s following
publication of the first U.S. Surgeon
General's report in 1964 (5) and the
broader public education campaigns ofthe
late 1960s and early 1970s (25).
These changes in smoking behavior
among various birth cohorts of black and
white men and women largely explain the
lung cancer mortality patterns observed in
the United States throughout this century
(1,21). Currently, black men experience
the highest lung cancer death rates of any
demographic group. However, until the
early 1960s white males experienced the
highest death rates (26). This pattern is
entirely consistent with the greater overall
smoking exposures that occurred among
those white (and not black) male cohorts
born before World War I (21,24).
As black male cohorts with greater
smoking exposures began to appear, and as
white males began to modify their behav-
ior, however, the national lung cancer mor-
tality pattern began to change (Figure 6).
Thus, in the early 1960s the black male
age-adjusted lung cancer mortality rate
exceeded that of whites and today is
approximately 30% higher than the rate of
their white male peers (27,28).
In contrast, only relatively small differ-
ences are seen between the overall smoking
behavior ofblack and white women across
individual birth cohorts during this century.
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Figure 4. Current smoking prevalence bycalendar yearfor 5-year birth cohorts of black males born between 1900 and 1969. Data from Burns et al. (24).
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Figure 5. Current smoking prevalence bycalendar yearfor5-year birth cohorts of blackfemales born between 1900 and 1969. Data from Burns et al. (24).
As a result, the lung cancer mortality expe-
rience ofblack and white women has been
nearly identical (27). In 1992, both the
age-adjusted lung cancer mortality rate and
the absolute number oflung cancer deaths
among black women were projected to
exceed those ofbreast cancer for the first
time. It is likely, therefore, that lung cancer
is now the leading cause of cancer death
among black women in the United States,
a phenomenon that occurred among white
women in 1986 (27). Lung cancer has been
the leading cause ofcancer mortality among
both blackandwhite men fordecades (26).
Cigarette Smoking and Early
Cancer Mortality
A series ofauthoritative reports issued by
the U.S. Surgeon General and others
conclusively document that cigarette
Environmental Health Perspectives
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1970 U.S. population. Data from Shopland (21).
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smoking is causally related to a host of
fatal diseases, including several major sites
of cancer (1-19). A list of these diseases
and their established epidemiologic associ-
ations with cigarette smoking is presented
in Table 1 [based in part on Shopland and
Burns (29)].
For some diseases, including four sites
of cancer, cigarette smoking is the single
largest contributor (defined as responsible
for half or more ofall deaths annually) to
Table 1. Causes of death and their established
epidemiological association with cigarette smoking.
Category Cause ofdeath
A Cancer of lung8
Chronic obstructive pulmonary disease
(includes emphysema)
Peripheral vascular disease
Cancer of larynxa
Cancer of oral cavity(pharynx)'
Cancer ofesophagus8
B Stroke
Coronary heart disease
Cancer of bladder8
Aortic aneurysm
Perinatal mortality
Cancer ofcervix uteri8
Leukemia (myeloid)8
C Gastric ulcerb
Duodenal ulcerb
Cancer of kidneya
Cancer ofpancreas8
Cor pulmonale
Cancer ofstomachab
Cancer of rectuma
Cancer ofcolon'
Pneumoniab
Cancer ofthe livera
SIDS
D Alcoholism
Cirrhosis of liver
Poisoning
Suicide
E Endometrial cancer8
Parkinson's disease
Ulcerative colitis
A, diseases for which a direct causal association has
been firmly established and smoking is considered the
single, major cause, i.e., responsible for half or more of
all deaths annually from the disease; B, diseases for
which a direct causal association has been firmly
established, but smoking is but one of known causes;
C, diseases forwhich smokers experience higher death
rates than nonsmokers, but the causal nature of the
association has not been clearly elucidated (for some
of these causes of death. D, causes of death for which
excess mortality in smokers has been observed, but
association is attributed to confounding; E, diseases
that epidemiological studies have consistently found to
have lowerdeath rates in smokers than in nonsmokers.
'Neoplastic disease sites now associated with ciga-
rette smoking. bA causal association is considered
highly probable.
excess mortality for these causes ofdeath.
In addition to these sites, cigarette smoking
is an established cause of other cancers
(category B in Table 1) and has been etio-
logically associated with several additional
cancer sites (category C in Table 1),
although for some sites the causal nature of
this association has not been fully eluci-
dated. Nonetheless, for each site listed in
the table, the death rates among current
smokers are greater than the death rates
among comparable nonsmokers and for
many a consistent dose-response trend has
been observed. For one site, endometrial
cancer (see category D in Table 1), studies
have consistently shown that cigarette
smoking is associated with a lower risk of
mortality (9,11,12,30). The evidence is
far from clear, however, as to whether
smoking actually protects women from
developing and dying from this cancer.
Cigarette Smoking andSite-Specific
CancerMortality
The mortality risks among both current
and former male and female smokers rela-
tive to nonsmokers for select cancer sites
are presented in Table 2. These data are
taken from the American Cancer Society
(ACS) prospective study involving over 1.2
million people in all 50 states (11,31).
For each major cancer site listed, the
mortality risk among current smokers is
significantly higher than 1.0; the risks
Table 2. Relative risks for major smoking-related
cancer sites among male and female smokers. ACS
50-State Study, 4-yearfollow-up.
Cancer site Current smokers8 Former smokersb
Males
Lung 22.36 9.36
Oral 27.48 8.80
Esophagus 7.60 5.83
Larynx 10.48 5.24
Bladder 2.86 1.90
Pancreas 2.14 1.12
Kidney 2.95 1.95
Females
Lung 11.94 4.69
Oral 5.59 2.88
Esophagus 10.25 3.16
Larynx 17.78 11.88
Bladder 2.58 1.85
Pancreas 2.33 1.78
Kidney 1.41 1.16
Cervix 2.14 1.94
'Current cigarette smokers are individuals who
reported they were smoking cigarettes regularly at
time of enrollment in this study. bFormer cigarette
smokers are individuals who reported they were not
smoking attime of enrollment in this study but smoked
cigarettes regularly in the past. Data from DHHS(11).
among former smokers are intermediate to
those of current smokers and those who
never smoked. Respiratory tract cancers
are particularly elevated in smokers, which
probably reflects the fact these sites are
most exposed to the carcinogens known to
exist in cigarette smoke (21). The risks of
developing any of the smoking-related
cancers is dose-related. That is, the greater
the exposure to cigarette smoke, the
greater the risk.
The risk for lung cancer is particularly
worth noting, as lung cancer now accounts
for nearly 30% ofall cancer deaths annually
in the United States (32). Lung cancer
mortality risks among current smokers
increase with increasing doses ofcigarette
smoke received, as measured by the number
of cigarettes consumed daily, duration
(years) ofsmoking, depth of inhalation,
early age ofinitiation, and tar content of
the brand smoked (4,5,9,11,19,29). Table
3 provides information by amount smoked
taken from a number ofthe larger prospec-
tive studies; several ofthese represent non-
U.S. populations. Many of these studies
have also followed substantial numbers of
women. Taken together, they represent
over 20 million person-years ofobservation.
In the ACS 50-state study initiated in
1982, the lung cancer mortality ratios
among male and female smokers, regardless
of the amount smoked, are 22 and 12,
respectively. As the number of cigarettes
consumed increases, lung cancer mortality
risks also increase. Males smoking more
than a pack of cigarettes per day experi-
enced a relative risk (RR) of27; for women
smoking 20 or more cigarettes (data not
shown in table), the RR is 16. Data from
the other studies show similar increases in
riskwith increasing dailyconsumption.
Various independent investigators and
government reports have consistently esti-
mated that cigarette use is responsible for
between 80 and 90% of all lung cancer
deaths annually in the United States
(31,33-35). In those countries and cultures
in which cigarette use has been an estab-
lished behavior for many decades, lung
cancer is also a significant cause of death
and often is the dominate form ofneoplastic
disease in thepopulation (36,37).
TheBenefits ofSmoking Cessation
onRelucedCancerRisk
While current cigarette smokers experience
substantial early cancer mortality, espe-
cially for cancers of the head and neck,
former cigarette smokers are observed to
have reduced mortality compared with
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Table 3. Lung cancer mortality ratios in men and women, by number of cigarettes smoked daily, major prospective
mortality studies.
Study, population
ACS 25-State Study, 1 million
British Doctors' Study, 40,000
U.S. Veterans' Study, 290,000
Japanese Study, 270,000
ACS 50 State Study, 1.2 million
Men
Cigarettes, day
Nonsmokers
All smokers
1-9
10-19
20-39
40+
Nonsmokers
All smokers
1-14
15-24
25+
Nonsmokers
All smokers
1-9
10-19
21-39
40+
Nonsmokers
All smokers
1-9
10-19
20+
Nonsmokers
All smokers
1-20
20+
Ratio
1.00
8.53
4.62
8.62
14.69
18.71
1.00
14.90
7.50
14.90
25.40
1.00
11.28
3.89
9.63
16.70
23.70
1.00
3.76
2.06
4.00
6.24
1.00
22.36
18.80
26.90
Data from Doll et al. (44), Doll et al. (66), Hrubec et al. (69), Rogot et al. (71),
Hirayama (74), Garfinkel and Stellman (75), Thun et al. (76), Thun et al. (77).
Women
Cigarettes, day
Nonsmokers
All smokers
1-9
10-19
20-39
40+
Nonsmokers
All smokers
1-14
15-24
25+
Ratio
1.00
3.58
1.30
2.40
4.90
7.50
1.00
5.00
1.28
6.41
29.71
Nonsmokers 1.00
All smokers 2.03
1-9 2.25
10-19 2.56
20+ 4.47
Nonsmokers 1.00
All smokers 11.94
1-10 5.50
11-19 11.20
20 14.20
21-30 20.40
31+ 22.00
Hammond (72), Hammond et al. (73),
Table 4. Relative risk of developing lung cancer by time since stopping smoking and total duration of smoking
behavior.
Time since stopping Duration ofsmoking habit
smoking, years 1-19 years 20-39 years 40-49 years >50 years
Men
0 1.ia 2.2 2.8 3.0
1-4 1.1 2.1 3.3 3.8
5-9 0.4 1.5 2.2 2.8
10+ 0.3 1.0 1.6 2.7
Women
o 1.ob 2.1 2.7 5.2
1-4 1.0 2.3 2.1 7.1
5-9 0.4 2.0 1.1 1.7
10+ 0.4 0.8 2.3
'Baseline category; risk for people who had never smoked relative to that for current smokers who had smoked for
one to 19 years was 0.3. bBaseline category; risk for people who had never smoked relative to that for current
smokers who had smoked for 1 to 19 years was 0.6. Data from Lubin et al. (38).
continuing smokers (9,11,12). For each of
the major smoking-associated cancer sites,
the risk among former smokers is lower
compared to that found among current
smokers, but their risk is still higher than
those who never smoked (12).
The data for lung cancerclearly illustrate
the benefit ofquirting smoking. In a large
case-control study by Lubin and colleagues
(38) involving over 7000 male and female
lung cancer patients, the risks declined for
both men and women with increases in the
number ofyears off cigarettes, although
among men the rate ofdecline was greater
for those males who had smoked for the
shorter length oftime (Table 4). After 10
years off cigarettes, individuals who had
smoked less than 20 years experienced a
lung cancer risk similar to those who had
never smoked. However, the risk remained
high among both sexes who reported smok-
ing for 20 years or more, regardless ofthe
time reported offcigarettes (39).
In the ACS 50-state study, an attempt
was made to examine the effect ofhealth
status on smoking cessation and its relation-
ship to reduced lung cancer mortality (12).
The lung cancer risk for those smokers who
reported no history ofheart disease, stroke
or cancer at the time ofenrollment were
compared with those for all respondents
(including those with and without a history
ofdisease) by the length oftime since quit-
ting smoking and the number ofcigarettes
consumed daily. The data for both men
and women are presented in Table 5.
Individuals who reported having quit
smoking for 2 years or less and who had
a history of chronic disease at time of
enrollment in the study experienced lung
cancer mortality risks that exceeded those
ofcontinuing smokers. In contrast, among
those individuals (both men and women)
who reported no history ofchronic disease,
lung cancer risk began to drop immediately
following cessation of smoking. Among
nearly 300,000 U.S. veterans, those who
quit smoking because of doctor's orders
experienced higher death rates than those
who quit for reasons other than doctor's
orders. It is likely that individuals who quit
smoking because ofexisting disease or poor
health status (possibly due to their smok-
ing) do not derive the same benefit from
stopping as those who quit out of concern
for future health considerations.
In both studies, lung cancer risk
decreased with increasing years ofcessation
ofsmoking; approximately 10 years follow-
ing cessation, the lung cancer risk among
former smokers was reduced by approxi-
mately half (29). These data also indicate,
however, that a measurable risk is still
apparent among former smokers who have
been off cigarettes 16 years or more, and
this risk was present even among smokers
who reported smoking less than a pack per
day (9,12,29).
For cancer of sites other than lung,
individuals who quit smoking face lower
risks of cancer than those individuals who
continue to smoke (11). For example,
quitting smoking approximately halves the
risks for oral, esophageal, and bladder
cancer within 5 years following cessation
(12,29). The risk for pancreatic cancer
is reduced in former smokers but may
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only be measurable after 10 years or more
ofabstinence (12,29).
Pipeand CigarSmoking
Regular use ofpipes and cigars is associated
with an increased risk of disease. In fact,
these forms oftobacco smoking are highly
correlated with cancers of the oral cavity,
larynx, and esophagus (5,9,11,19). Both
prospective and retrospective studies have
consistently found that pipe and cigar
smokers experience mortality risks from
these sites that equal and sometimes exceed
the risks found in cigarette smokers (9).
Additionally, pipe and cigar smokers also
experience higher lung cancer mortality
risks than nonusers. In a large case-control
study in Western Europe, compared to
nonsmokers, risks for lung cancer among
males smoking cigars only and pipes only
were 2.5 and 2.9, respectively (40). There
were significant trends of increased risk
with years of use and with numbers of
cigars and pipes smoked per day. The
lower lung cancer risk among users ofthese
products compared with that among ciga-
rette smokers probably reflects the fact that
"pure" pipe and cigar users (those who
have only smoked these products and not
cigarettes) do not report active inhalation
of the smoke. Unfortunately, many life
long cigarette smokers switch to pipes and
cigars believing that by doing so they are
lowering their risk of disease, but they
often continue to inhale (41).
Public Health Burden
ofCigarette Use
on Cancer Mortality
A number of published estimates have
appeared in the scientific literature in an
attempt to depict the cancer burden attri-
buted to cigarette use in the United States
(9,31,33-35,42). In general, these studies
have demonstrated that approximately
one-third ofall cancer deaths annually can
be reasonably attributed to cigarette smok-
ing. In an analysis previously published,
NCI and ACS investigators estimated that
cigarette smoking was responsible for
about 157,000 of the 514,000 cancer
deaths expected to occur in the United
States in 1991, or about 31% ofall cancer
deaths that year (31). These totals, how-
ever, did not consider those cancer deaths
that could be attributed to the pipe and
cigar smoking among men, the contribu-
tion ofsmokeless tobacco use to oral can-
cer mortality, or those lung cancer deaths
among nonsmokers that resulted from
exposure to environmental tobacco smoke.
Table 5. Standard mortality ratios of lung cancer among former smokers in ACS-CPS II (relative to those who had
never smoked) by years of smoking abstinence, daily cigarette consumption at time of cessation, and history of
chronic disease.
No history of chronic disease All respondents
1-20 cigarettes/day .21 cigarettes/day 1-20cigarettes/day .21 cigarettes/day
Males
Current smokers 23.5 31.5 18.8 26.9
Former smokers,
years since stopped
< 1 16.8 23.4 26.7 50.7
1-2 16.7 25.3 22.4 33.2
3-5 19.7 20.5 16.5 20.9
6-10 8.6 14.2 8.7 15.0
11-15 6.3 13.6 6.0 12.6
.16 3.3 5.3 3.1 5.5
No history of chronic disease All respondents
1-19 cigarettes/day .20 cigarettes/day 1-19 cigarettes/day .20 cigarettes/day
Females
Current smokers 10.5 24.1 7.3 16.3
Former smokers,
years since stopped
<1 3.4 21.1 7.9 34.3
1-2 9.0 18.2 9.1 19.5
3-5 2.5 13.2 2.9 14.6
6-10 1.1 12.0 1.0 9.1
11-15 1.1 2.9 1.5 5.9
.16 1.6 2.4 1.4 2.6
Data from DHHS (12).
Table 6 provides an updated estimate of
the 1995 cancer burden from cigarette
smoking for the United States. The data in
this table are based on cancer mortality pro-
jections published annually by the ACS
(32). The percent attributable risk is
derived using a standard attributable risk
methodology for two levels of exposure
(43) using smoking prevalence estimates
from the National Health Interview Survey,
conducted by the National Center for
Health Statistics. In 1993, 27.7% ofadult
men and 22.5% of adult women were
classified as current smokers; 29.9% ofmen
and 19.7% ofwomen were former smokers.
Nearly 60% of women (57.8%) never
smoked compared with 42.4% ofmen.
In this analysis we limited the data to
the same eight major cancer sites previously
mentioned (31) that have been tradition-
ally considered causally related to cigarette
smoking, although clearly additional cancer
sites could have been included. Thus, the
smoking attributed fraction should be con-
sidered conservative. This method produces
an estimate of 168,057 cigarette-only excess
cancer deaths in 1995 of 547,000 total
cancer deaths expected. The term "excess"
deaths is used in the sense that these deaths
would not have occurred ifcigarette smok-
ers experienced the same death rates as
nonsmokers. While the vast majority ofthe
smoking-related excess deaths are due to
Table 6. 1995 U.S. cancer deaths caused by cigarette
smoking.
Estimated
1995 cancer Smoking deaths
Site and ICD deaths attributable due to
disease category expected risk, % smoking
Males
Oral,140-149 5,480 90.6 4,965
Esophagus,150 8,200 76.6 6,282
Pancreas,157 13,200 25.9 3,419
Larynx,161 3,200 79.6 2,547
Lung,162 95,400 89.4 85,288
Bladder,188 7,500 43.8 3,285
Kidney,189 7,100 45.1 3,202
Total cancer
deaths expected 289,000 108,988
Females
Oral,140-149 2,890 58.5 1,691
Esophagus,150 2,700 71.5 1,931
Pancreas,157 13,800 31.0 4,278
Larynx,161 890 85.5 761
Lung,162 62,000 76.1 47,182
Cervix,180 4,800 30.6 1,469
Bladder,188 3,700 34.2 1,265
Kidney,189 4,600 10.7 492
Total cancer
deaths expected 258,000 59,069
Total male and female cancer
deaths expected in 1995 547,000
Total excess deaths due to
cigarette smoking 168,057
Percent of cancer deaths due
to cigarette smoking in 1995 30.7
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respiratory tract cancers, especially cancer
ofthe lung, a significant number ofexcess
deaths occur in other sites. The data also
indicate that the cigarette-attributable frac-
tion (percent) has remained relatively con-
stant over time for both men and women,
at around 38 and 23%, respectively.
Just as important, many of these sites
have extremely poor 5-year survival rates
and have changed little in absolute terms
over the past 25 years (31). Only about
12% of all patients diagnosed with lung
cancer survive 5 years, and the survival rates
for cancers ofthe pancreas and esophagus
are even more dismal (27,32).
Cigarette Smoking and
Overall Cancer Mortality
Because ofthe large number ofcancer sites
associated with smoking, its not surprising
that the overall cancer risk in smokers
compared with that in nonsmokers is sub-
stantially elevated. In the ACS 50-State
study, which followed 1.2 million men and
women for 6 years, male smokers, regard-
less of the amount smoked, experienced
overall cancer mortality risks that were
350% higher than those of nonsmokers
(3.50 RR); the risk for women who smoked
was nearly 200% greater (1.86 RR) (4).
Among 34,000 male British physicians fol-
lowed prospectively for 40 years, Doll et al.
observed an overall cancer mortality risk
more than 200% greater among current
smokers, and this risk increased as amounts
smoked daily increased (44). Similar
findings have been observed in other cohort
studies published to date. Ifthe cancer bur-
den attributed to cigarette smoking pre-
sented in Table 6 were based on overall
cancer mortality ratios rather than on the
individual cause-specific mortality rates, the
total number ofexcess cancer deaths would
easilyapproach 200,000 annually.
Smokeless Tobacco Use
as a Cause of Cancer
Until recently, little public health attention
was focused on chewing tobacco or snuff
use (commonly referred to as smokeless
tobacco), as it constituted only a very small
percentage of all tobacco consumed.
Furthermore, until the mid-1970s, both
total consumption and prevalence of use
for both these products were declining
(2,45). These trends began to reverse coin-
cident with the introduction and mass
marketing of new forms ofsnuff-moist
snuff, to be specific, which is sold under
such brand names as Skoal, Copenhagen,
Happy Days, and Red Man (2).
Unlike cigarette advertising, which was
banned from the public airways by the
U.S. Congress in 1971 (46), advertisers of
smokeless tobacco until recently have been
free to use radio and television to promote
their products. Until Congress extended
the ban to include smokeless tobacco in
1987 (47), these products were heavily
advertised on television, by famous athletes
such as running backs Walt Garrison ofthe
Dallas Cowboys and Earl Campbell ofthe
Houston Oilers, baseball star George Brett,
andwell-known entertainers such as country
and western star Charlie Daniels (2). As a
result, consumption ofmoist snuffincreased
rapidly. In the 10-year period between 1982
and 1992, total snuff consumption in the
United States increased by 12 million
pounds (from 44 million to 56 million
pounds), with moist snuff accounting for
nearly all ofthis increase (48).
More important, the group that experi-
enced the greatest increase in smokeless
tobacco use was adolescents and young
adults (49). This increase has been directly
attributed to the youth-related advertising
themes and messages used during this
period oftime. Television was the primary
mode of such advertising, which often
appeared during sports events or during
prime-time viewing hours (2). Today
about 6% ofall males 18 years and older
are regular users of smokeless tobacco; a
significant proportion of this number is
under the age of30 (35) (Table 7).
Table 7. Smokeless tobacco use among adult males,
age 18 and older, by product category, United States,
1970 and 1991.
Product category 1970 1991
Chewing tobacco
Age: 18-24 1.8 4.1
25-34 2.2 3.1
35-44 3.3 2.5
45-64 4.2 2.4
.65 9.4 3.9
Total 3.9 3.1
Snuff
Age: 18-24 0.7 6.2
25-34 0.5 4.8
35-44 0.8 2.9
45-64 1.8 1.4
.65 4.0 2.2
Total 1.5 3.3
Any smokeless tobacco
Age: 18-24 2.2 8.4
25-34 2.5 6.9
35-44 3.9 4.9
45-64 5.8 3.7
265 12.7 5.6
Total 5.2 5.6
Data from CDC (35).
A number ofepidemiological investiga-
tions were initiated concurrent with this
rapid increase in consumption to assess
whether use of smokeless tobacco was
harmful. In 1981, Winn and colleagues
(50) investigated the risks ofsnuff use on
the incidence oforal and pharyngeal cancer
among 255 women in North Carolina.
The investigators found a 4-fold increase in
risk among nonsmoking women who
dipped snuff. For cancers of the gum and
buccal mucosa, a strong dose-response
effect was observed when measured by
duration ofuse (Table 8).
Two major reviews on the health con-
sequences ofsmokeless tobacco use, both
ofwhich cite U.S. as well as international
studies, found similar results (45,51). The
1986 report of the Public Health Service
(PHS) Advisory Committee to the U.S.
Surgeon General (45) stated:
After a careful examination of the
relevant epidemiologic, experimen-
tal, and clinical data, the committee
concludes that the oral use ofsmoke-
less tobacco represents a significant
health risk. It is not a safe substitute
for smoking cigarettes. It can cause
cancer and a number of noncancer-
ous oral conditions and can lead to
nicotine addiction and dependence.
Both reviews concluded that the evidence
was strong that snuff use, particularly
moist snuff, was a cause of cancer in
humans, but the evidence for chewing
tobacco was less clear.
No estimates exist to demonstrate the
cancer burden that might reasonably be
attributed to smokeless tobacco use. How-
ever, given the magnitude of the disease
risks associated with smokeless tobacco use,
especially for cancers of the oral cavity,
there is no doubt that regular use of
smokeless tobacco contributes some addi-
tional cancer cases and deaths annually.
Table 8. Estimated relative risk of oropharyngeal can-
cer according to duration of snuff use and anatomic
site.
Anatomic
site
Duration of
snuff use, years
Relative risk
estimate
Gum and buccal 0 1.0
mucosa 1-24 13.8
25-49 12.6
>50 48.0
Other mouth and 0 1.0
pharynx 1-24 1.7
25-49 3.8
>50 1.3
Data from Winn et al. (50).
Environmental Health Perspectives 138TOBACCO USEANDEARLYCANCERMORTALITY
Furthermore, given the relatively recent
rise in moist snuff use by adolescents-
moist snuff is the most dangerous form of
smokeless tobacco-public health officials
have voiced concern that an increased inci-
dence oforal cancer may arise as this bolus
of new users ages (2,52). Just as the lung
cancer epidemic did not begin until some
25 to 30 years following the large-scale
uptake and regular use ofcigarettes around
World War I, the next tobacco-related
epidemic could well be oral cancers during
the early part ofthe 21st century (2).
Environmental Tobacco
Smoke and Lung Cancer
in Nonsmokers
By the beginning of the 1960s, the evi-
dence linking cigarette smoking to early
lung cancer mortality was overwhelming.
By the time the Advisory Committee to
the Surgeon General issued its now-famous
report in 1964, more than 60 retrospective
and prospective studies documenting this
association existed in the scientific litera-
ture. For lung cancer, a measurable eleva-
tion in risk was consistently seen in those
individuals who reported being only light
or occasional cigarette smokers or who
reported not inhaling during smoking (3).
This elevation in risk, at relatively low
exposure levels, prompted some public
health officials to question whether the lev-
els of tobacco smoke to which most non-
smokers were being exposed could also
pose a health threat (53).
In 1971 then-Surgeon General Jesse
Steinfeld directed that a complete review
of the topic be prepared for the next
Surgeon General's report (54). At that
time no direct epidemiological evidence
existed linking environmental tobacco
smoke (ETS) to chronic disease health
risks in nonsmokers. However, in the early
1970s the first epidemiological studies
appeared documenting that infants and
young children exposed to ETS experi-
enced higher rates ofrespiratory problems,
including hospital admissions for respira-
tory tract infections, than children from
nonsmoking households (55).
In 1981, two studies were published-
from Japan and Greece-showing a statis-
tically significant elevation in lung cancer
among never-smoking wives married to
smoking husbands (56,57). Both studies
also observed a greater lung cancer risk
among those nonsmoking women whose
husbands were classified as heavy smokers.
A U.S. prospective study published later
that same year was also positive but not
statistically significant (58).
By the time the National Academy of
Sciences and the U.S. Surgeon General
issued their independent assessments in
1986 (10,59), a total of 13 epidemiologi-
cal studies existed in the peer-reviewed
literature on ETS and lung cancer in
nonsmokers. Most studies (11 of 13)
demonstrated a positive association, and in
6 the risk was significant. Both reports
concluded that ETS was a cause of lung
cancer in nonsmokers.
In 1990 the U.S. Environmental
Protection Agency (U.S. EPA) undertook
the most complete review ofthis question.
By the time the U.S. EPA issued its
report, "Respiratory Health Effects of
Passive Smoking: Lung Cancer and Other
Disorders," 30 epidemiological studies
were available for analysis (3). The 30
studies reviewed comprised more than
3,000 lung cancer cases from eight differ-
ent countries and employed a wide variety
ofstudy designs and protocols (Table 9).
Twenty-four of 30 studies reported a
higher risk of lung cancer among never-
smokers ever exposed to ETS, and 9 were
statistically significant. Furthermore, every
1 ofthe 17 studies that categorized risk by
level of spousal smoking showed an
increased risk among those most heavily
exposed, and 9 were statistically significant
in spite ofmost having low statistical power
to detect an increase. Ofthe 14 studies for
which dose-response trends could be
tested, 10 were statistically significant-a
result that would occur by chance less than
1 in 1 billion (3).
In conducting a formal risk assessment
to establish the carcinogenic potential of a
low-level exposure to an environmental
agent, it is rare to have such a large epi-
demiologic base upon which to make
scientific judgments. It is especially rare
when the population data being examined
Table 9. ETS and lung cancer: pooled data by country,
results from 30 studies.
Country and number
of studies
Greece (2)
Hong Kong (4)
Japan (5)
United States (11)
Western Europe (4)
China (4)
All studies combined
Overall risk'
2.01
1.48
1.41
1.19
1.17
0.95
1.30
High
relative riska
2.15
1.68
1.96
1.38
3.11
2.32
1.81b
'All relative risk is adjusted for smoker misclassifica-
tion. bp=<0.000001. Data from U.S. EPA(3).
are based on actual levels ofexposure that
people encounter in their everyday activi-
ties. This is in sharp contrast to other risk
assessments for which the only epidemio-
logic data are from populations with histo-
ries ofvery high occupational exposures to
an agent (for example, asbestos workers
and uranium miners) and the risk estimates
at low exposures are extrapolated on the
basis of mathematical models. Of all the
agents U.S. EPA has classified as a Group
A (known human carcinogen), ETS is the
only agent for which an increased cancer
risk has actually been observed at typical
environmental levels ofexposure (3).
ETS is also a significant source ofpre-
ventable cancer mortality. U.S. EPA esti-
mates that ETS exposure is responsible for
approximately 3,000 nonsmoker lung can-
cer deaths annually. This is approximately
the number oflung cancer deaths that U.S.
EPA estimates to be attributable to indoor
radon exposure and is at least an order of
magnitude higher than the number ofcan-
cer deaths U.S. EPA attributes to nonoccu-
pational asbestos exposure in our homes,
worksites, and schools (60,61).
Two British investigators have esti-
mated that living or working in buildings
containing asbestos is associated with an
annual risk oflung cancer ofless than 1 in
1,000,000, a rate deemed unacceptable, as
evidenced by the efforts made to remove
asbestos from workplaces, schools, and
other public buildings (62). These same
investigators state that the relative risk for
lung cancer due to ETS "is more than 100
times higher than the estimated effects of
20 years' exposure to the amount of
chrysotile asbestos normally found in
asbestos containing buildings"(63).
In summary, tobacco use, especially
the practice of cigarette smoking, is the
single largest contributor to cancer mortal-
ity in the United States, and is responsible
for nearly one-third of all cancer deaths
annually; 38% ofall male and 23% ofall
female cancer deaths are directly related to
cigarette use.
Cigarette smoking increases the death
rate in smokers for at least 14 individual
sites, and for several, cigarette smoking
contributes to half or more of all such
deaths annually. Of these, lung cancer is
clearly the most important because of
its significant impact on national cancer
vital statistics.
Pipe and cigar smoking is not without
significant disease risk; regular users of
such products experience increased risks for
several sites ofcancer, especially cancer of
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the oral cavity. Pipe and cigar smokers are
also at increased risk for cancers of the
larynx, esophagus, and lung.
Use of smokeless tobacco, especially
newer forms of moist snuff, is carcino-
genic to humans. Long-term users experi-
ence up to a 50-fold increased risk for
cancers of the cheek and gum compared
with nonusers.
Environmental tobacco smoke is now
an established cause oflung cancer in non-
smokers and has been labeled a Group A
(known human) carcinogen by the U.S.
EPA. ETS is the only agent ever classified
as a Group A carcinogen for which the
increased cancer risks were based on typi-
cal environmental levels of exposure.
Between 3,000 and 6,000 lung cancer
deaths annually are attributed to ETS
exposures in nonsmokers.
Were it not for the historically high
tobacco use rates observed in the United
States during this century, we could be wit-
nessing a decline in the overall cancer death
rate instead of the small but persistent
increases noted over the past 50 years.
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